{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T02:09:28Z","timestamp":1780106968911,"version":"3.54.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82222902"],"award-info":[{"award-number":["82222902"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.diabres.2026.113156","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:39:01Z","timestamp":1770943141000},"page":"113156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Optimising lipid monitoring interval for primary prevention of cardiovascular disease in patients with type-2 diabetes: A target trial emulation study"],"prefix":"10.1016","volume":"234","author":[{"given":"Boyuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily Tsui Yee","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine Sze Ling","family":"Chui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy Lo Kuen","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric Yuk Fai","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2026.113156_b0005","unstructured":"WHO. Global Health Estimates: Life expectancy and leading causes of death and disability [Available from: https:\/\/www.who.int\/data\/gho\/data\/themes\/mortality-and-global-health-estimates\/ghe-leading-causes-of-death."},{"issue":"1","key":"10.1016\/j.diabres.2026.113156_b0010","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12933-018-0728-6","article-title":"Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017","volume":"17","author":"Einarson","year":"2018","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"10.1016\/j.diabres.2026.113156_b0015","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12933-022-01516-6","article-title":"Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management","volume":"21","author":"Ma","year":"2022","journal-title":"Cardiovasc Diabetol"},{"issue":"9","key":"10.1016\/j.diabres.2026.113156_b0020","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/dme.13416","article-title":"Annual direct medical costs associated with diabetes-related complications in the event year and in subsequent years in Hong Kong","volume":"34","author":"Jiao","year":"2017","journal-title":"Diabet Med"},{"issue":"15","key":"10.1016\/j.diabres.2026.113156_b0025","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1056\/NEJMoa1608664","article-title":"Mortality and cardiovascular disease in type 1 and type 2 diabetes","volume":"376","author":"Rawshani","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2026.113156_b0030","first-page":"S216","article-title":"10. Cardiovascular disease and risk management: standards of care in diabetes\u20142026","volume":"49(Supplement_1)","author":"Bajaj","year":"2026","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2026.113156_b0035","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/1476-511X-13-183","article-title":"Lipid profile abnormalities seen in T2DM patients in primary healthcare in Turkey: a cross-sectional study","volume":"13","author":"Ozder","year":"2014","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.diabres.2026.113156_b0040","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2147\/VHRM.S209830","article-title":"High level of individual lipid profile and lipid ratio as a predictive marker of poor glycemic control in type-2 diabetes mellitus","volume":"15","author":"Artha","year":"2019","journal-title":"Vasc Health Risk Manag"},{"issue":"24","key":"10.1016\/j.diabres.2026.113156_b0045","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1016\/j.jacc.2018.11.002","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: executive summary: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.diabres.2026.113156_b0050","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.l2319","article-title":"Are guidelines for monitoring chronic disease in primary care evidence based?","author":"Elwenspoek","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.diabres.2026.113156_b0055","unstructured":"National Institute for Health and Care Excellence: Clinical Guidelines. Cardiovascular disease: risk assessment and reduction, including lipid modification. London: National Institute for Health and Care Excellence (NICE); 2023."},{"issue":"8","key":"10.1016\/j.diabres.2026.113156_b0060","first-page":"1129","article-title":"2021 Canadian cardiovascular society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in adults","volume":"37","author":"Pearson","year":"2021","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.diabres.2026.113156_b0065","unstructured":"Hong Kong Reference Framework for Diabetes Care for Adults in Primary Care Settings. Primary Healthcare Office, Food and Health Bureau (Hong Kong); 2023."},{"key":"10.1016\/j.diabres.2026.113156_b0070","unstructured":"Society CD. Guideline for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition). Chin J Diabetes Mellitus. 2021;13(4):95."},{"issue":"6","key":"10.1016\/j.diabres.2026.113156_b0075","doi-asserted-by":"crossref","first-page":"436","DOI":"10.7326\/0003-4819-149-6-200809160-00018","article-title":"Monitoring cholesterol levels: understanding variance and finding the most useful data","volume":"149","author":"Cayley","year":"2008","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.diabres.2026.113156_b0080","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1136\/hrt.2009.172619","article-title":"Lipid re-screening: what is the best measure and interval?","volume":"96","author":"Takahashi","year":"2010","journal-title":"Heart"},{"issue":"9","key":"10.1016\/j.diabres.2026.113156_b0085","doi-asserted-by":"crossref","first-page":"656","DOI":"10.7326\/0003-4819-148-9-200805060-00005","article-title":"Monitoring cholesterol levels: measurement error or true change?","volume":"148","author":"Glasziou","year":"2008","journal-title":"Ann Intern Med"},{"issue":"100","key":"10.1016\/j.diabres.2026.113156_b0090","doi-asserted-by":"crossref","DOI":"10.3310\/hta191000","article-title":"Optimal strategies for monitoring lipid levels in patients at risk or with cardiovascular disease: a systematic review with statistical and cost-effectiveness modelling","volume":"19","author":"Perera","year":"2015","journal-title":"Health Technol Assess"},{"issue":"6","key":"10.1016\/j.diabres.2026.113156_b0095","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/ajr.12283","article-title":"Patterns of type 2 diabetes monitoring in rural towns: how does frequency of HbA1c and lipid testing compare with existing guidelines?","volume":"24","author":"Paul","year":"2016","journal-title":"Aust J Rural Health"},{"key":"10.1016\/j.diabres.2026.113156_b0100","unstructured":"AUTHORITY QAS-coCCoDSH. Hospital Authority Diabetes Mellitus Care Report 2019\/20."},{"key":"10.1016\/j.diabres.2026.113156_b0105","article-title":"Are guidelines for monitoring chronic disease in primary care evidence based?","volume":"365","author":"Elwenspoek","year":"2019","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.diabres.2026.113156_b0110","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1309\/AJCPYXDAUS2F8XJY","article-title":"Inappropriate repeats of six common tests in a Canadian city: a population cohort study within a laboratory informatics framework","volume":"144","author":"Morgen","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.diabres.2026.113156_b0115","unstructured":"Authority H. Clusters, Hospitals & Institutions 2023 [cited 2023 12\/04]. Available from: https:\/\/www.ha.org.hk\/visitor\/ha_visitor_index.asp?Content_ID=10036&Dimension=100."},{"key":"10.1016\/j.diabres.2026.113156_b0120","unstructured":"Quality Assurance Sub-committee of Central Committee on Diabetic Service HA. Hospital Authority Diabetes Mellitus Care Report 2019\/20."},{"key":"10.1016\/j.diabres.2026.113156_b0125","article-title":"Cardiovascular outcomes associated with use of clarithromycin: population based study","volume":"352","author":"Wong","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.diabres.2026.113156_b0130","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/1472-6963-8-138","article-title":"Health services research in the public healthcare system in Hong Kong: an analysis of over 1 million antihypertensive prescriptions between 2004-2007 as an example of the potential and pitfalls of using routinely collected electronic patient data","volume":"8","author":"Wong","year":"2008","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.diabres.2026.113156_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(24)00353-0","article-title":"Comparative effectiveness of combination therapy with nirmatrelvir-ritonavir and remdesivir versus monotherapy with remdesivir or nirmatrelvir-ritonavir in patients hospitalised with COVID-19: a target trial emulation study","author":"Choi","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"10.1016\/j.diabres.2026.113156_b0140","doi-asserted-by":"crossref","first-page":"701","DOI":"10.7326\/M24-0004","article-title":"Benefits and risks associated with statin therapy for primary prevention in old and very old adults : real-world evidence from a target trial emulation study","volume":"177","author":"Xu","year":"2024","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.diabres.2026.113156_b0145","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1111\/dom.15503","article-title":"Evaluating different low-density lipoprotein cholesterol thresholds to initiate statin for prevention of cardiovascular diseases in patients with type 2 diabetes mellitus: a target trial emulation study","volume":"26","author":"Wan","year":"2024","journal-title":"Diabetes Obes Metab"},{"issue":"10","key":"10.1016\/j.diabres.2026.113156_b0150","article-title":"Association between BNT162b2 and CoronaVac vaccination and risk of CVD and mortality after COVID-19 infection: a population-based cohort study","volume":"4","author":"Wan","year":"2023","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.diabres.2026.113156_b0155","unstructured":"Type 2 diabetes in adults: management. NICE Guideline: London: National Institute for Health and Care Excellence (NICE); 2022."},{"issue":"8","key":"10.1016\/j.diabres.2026.113156_b0160","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/aje\/kwv254","article-title":"Using big data to emulate a target trial when a randomized trial is not available","volume":"183","author":"Hern\u00e1n","year":"2016","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.diabres.2026.113156_b0165","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/ije\/dyaa223","article-title":"Versatility of the clone-censor-weight approach: response to \u201ctrial emulation in the presence of immortal-time bias\u201d","volume":"50","author":"Zhao","year":"2021","journal-title":"Int J Epidemiol"},{"issue":"4","key":"10.1016\/j.diabres.2026.113156_b0170","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/EDE.0000000000001608","article-title":"Comparative safety of gout treatment strategies on cardiovascular outcomes using observational data: clone-censor-weight target trial emulation approach","volume":"34","author":"Yoshida","year":"2023","journal-title":"Epidemiology"},{"key":"10.1016\/j.diabres.2026.113156_b0175","article-title":"How to estimate the effect of treatment duration on survival outcomes using observational data","volume":"360","author":"Hern\u00e1n","year":"2018","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.diabres.2026.113156_b0180","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/EDE.0000000000001601","article-title":"Emulating target trials to avoid immortal time bias - an application to antibiotic initiation and preterm delivery","volume":"34","author":"Caniglia","year":"2023","journal-title":"Epidemiology"},{"issue":"10","key":"10.1016\/j.diabres.2026.113156_b0185","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1038\/s41591-019-0597-x","article-title":"Avoidable flaws in observational analyses: an application to statins and cancer","volume":"25","author":"Dickerman","year":"2019","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.diabres.2026.113156_b0190","doi-asserted-by":"crossref","first-page":"e1322","DOI":"10.1212\/WNL.0000000000010433","article-title":"Emulating a target trial of statin use and risk of dementia using cohort data","volume":"95","author":"Caniglia","year":"2020","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.diabres.2026.113156_b0195","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1093\/ije\/dyv295","article-title":"Using observational data to emulate a randomized trial of dynamic treatment-switching strategies: an application to antiretroviral therapy","volume":"45","author":"Cain","year":"2016","journal-title":"Int J Epidemiol"},{"issue":"1","key":"10.1016\/j.diabres.2026.113156_b0200","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12874-016-0248-6","article-title":"A comparison of time dependent Cox regression, pooled logistic regression and cross sectional pooling with simulations and an application to the Framingham Heart Study","volume":"16","author":"Ngwa","year":"2016","journal-title":"BMC Med Res Method"},{"issue":"2","key":"10.1016\/j.diabres.2026.113156_b0205","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1053\/j.ajkd.2024.08.012","article-title":"Stopping versus continuing metformin in patients with advanced CKD: a nationwide Scottish target trial emulation study","volume":"85","author":"Lambourg","year":"2025","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.diabres.2026.113156_b0210","article-title":"Impact of beta-blockers on mortality and cardiovascular disease outcomes in patients with obstructive sleep apnoea: a population-based cohort study in target trial emulation framework","volume":"33","author":"Chen","year":"2023","journal-title":"Lancet Reg Health Eur"},{"issue":"4","key":"10.1016\/j.diabres.2026.113156_b0215","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1177\/1536867X0400400403","article-title":"Controlling for time-dependent confounding using marginal structural models","volume":"4","author":"Fewell","year":"2004","journal-title":"Stata J: Promot Commun Stat Stata"},{"issue":"1","key":"10.1016\/j.diabres.2026.113156_b0220","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3143\/geriatrics.43.27","article-title":"Reviewing the definition of elderly","volume":"43","author":"Orimo","year":"2006","journal-title":"Nihon Ronen Igakkai Zasshi"},{"key":"10.1016\/j.diabres.2026.113156_b0225","doi-asserted-by":"crossref","DOI":"10.1111\/dom.15745","article-title":"Development and validation of 10-year risk prediction models of cardiovascular disease in Chinese type 2 diabetes mellitus patients in primary care using interpretable machine learning-based methods","author":"Dong","year":"2024","journal-title":"Diabetes Obes Metab"},{"issue":"6","key":"10.1016\/j.diabres.2026.113156_b0230","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study","volume":"117","author":"D'Agostino","year":"2008","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.diabres.2026.113156_b0235","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1007\/s00125-013-2940-y","article-title":"UKPDS outcomes model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom prospective Diabetes Study: UKPDS 82","volume":"56","author":"Hayes","year":"2013","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.diabres.2026.113156_b0240","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.mayocp.2019.02.015","article-title":"Reducing the burden of false-positive tests: it is time to optimize diagnostic testing for undifferentiated conditions","volume":"94","author":"Tapper","year":"2019","journal-title":"Mayo Clin Proc"},{"issue":"9","key":"10.1016\/j.diabres.2026.113156_b0245","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/imj.14428","article-title":"The cost of repetitive laboratory testing for chronic disease","volume":"49","author":"Ko","year":"2019","journal-title":"Intern Med J"},{"key":"10.1016\/j.diabres.2026.113156_b0250","first-page":"241","article-title":"Sex-specific differences in lipid and glucose metabolism","volume":"5","author":"Varlamov","year":"2014","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.diabres.2026.113156_b0255","doi-asserted-by":"crossref","DOI":"10.1007\/s12020-024-03772-w","article-title":"Early onset type 2 diabetes mellitus: an update","author":"Strati","year":"2024","journal-title":"Endocrine"},{"issue":"3","key":"10.1016\/j.diabres.2026.113156_b0260","doi-asserted-by":"crossref","first-page":"638","DOI":"10.2337\/diacare.28.3.638","article-title":"Youth type 2 diabetes: insulin resistance, beta-cell failure, or both?","volume":"28","author":"Gungor","year":"2005","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.diabres.2026.113156_b0265","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00592-017-0981-2","article-title":"Relationship between healthy lifestyle behaviors and cardiovascular risk factors in chinese patients with type 2 diabetes mellitus: a subanalysis of the CCMR-3B STUDY","volume":"54","author":"Huang","year":"2017","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.diabres.2026.113156_b0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.109216","article-title":"Medication adherence in young adults with youth-onset type 2 diabetes: iCount, an observational study","volume":"184","author":"Trief","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"issue":"10","key":"10.1016\/j.diabres.2026.113156_b0275","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.36964","article-title":"Antihypertensive and lipid-lowering medication adherence in young adults with youth-onset type 2 diabetes","volume":"6","author":"Weinstock","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.diabres.2026.113156_b0280","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ypmed.2019.02.003","article-title":"The importance of cholesterol follow-up testing under current statin treatment guidelines","volume":"121","author":"Dansinger","year":"2019","journal-title":"Prev Med"},{"issue":"7","key":"10.1016\/j.diabres.2026.113156_b0285","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.amjcard.2006.04.025","article-title":"Usefulness of follow-up low-density lipoprotein cholesterol level as an independent predictor of changes of coronary atherosclerotic plaque size as determined by intravascular ultrasound analysis after statin (atorvastatin or simvastatin) therapy","volume":"98","author":"Hong","year":"2006","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.diabres.2026.113156_b0290","article-title":"Retrospective analysis of the cholesterol levels in a European mid-latitude population between 2007 and 2018: controversies and therapeutic implications","volume":"91","author":"Ferrari","year":"2020","journal-title":"Acta Biomed"},{"issue":"2","key":"10.1016\/j.diabres.2026.113156_b0295","first-page":"123","article-title":"Relationship between dyslipidaemia and glycaemic status in patients with Type 2 diabetes mellitus","volume":"38","author":"Thambiah","year":"2016","journal-title":"Malays J Pathol"},{"issue":"19","key":"10.1016\/j.diabres.2026.113156_b0300","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.2174\/0929867321666131227162950","article-title":"Obesity, hypertension and hypercholesterolemia as risk factors for atherosclerosis leading to ischemic events","volume":"21","author":"van Rooy","year":"2014","journal-title":"Curr Med Chem"},{"issue":"26","key":"10.1016\/j.diabres.2026.113156_b0305","doi-asserted-by":"crossref","first-page":"34121","DOI":"10.1007\/s11356-021-14109-9","article-title":"Management of oxidative stress and inflammation in cardiovascular diseases: mechanisms and challenges","volume":"28","author":"Donia","year":"2021","journal-title":"Environ Sci Pollut Res Int"},{"issue":"3","key":"10.1016\/j.diabres.2026.113156_b0310","doi-asserted-by":"crossref","first-page":"244","DOI":"10.2174\/1570161120666220201160038","article-title":"The role of inflammation as a preponderant risk factor in cardiovascular diseases","volume":"20","author":"Garc\u00eda","year":"2022","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.diabres.2026.113156_b0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113238","article-title":"Oxidative stress - complex pathological issues concerning the hallmark of cardiovascular and metabolic disorders","volume":"152","author":"Rotariu","year":"2022","journal-title":"Biomed Pharmacother"},{"issue":"23","key":"10.1016\/j.diabres.2026.113156_b0320","doi-asserted-by":"crossref","first-page":"e535","DOI":"10.1161\/CIR.0000000000000450","article-title":"Contributory risk and management of comorbidities of hypertension, obesity, diabetes mellitus, hyperlipidemia, and metabolic syndrome in chronic heart failure: a scientific statement from the american heart association","volume":"134","author":"Bozkurt","year":"2016","journal-title":"Circulation"},{"issue":"21\u201322","key":"10.1016\/j.diabres.2026.113156_b0325","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/j.cca.2010.07.022","article-title":"Managing the demand for laboratory testing: options and opportunities","volume":"411","author":"Janssens","year":"2010","journal-title":"Clin Chim Acta"},{"issue":"17","key":"10.1016\/j.diabres.2026.113156_b0330","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1001\/jamainternmed.2013.7495","article-title":"Can physicians change their laboratory test ordering behavior? a new look at an old issue","volume":"173","author":"Schroeder","year":"2013","journal-title":"JAMA Intern Med"},{"issue":"1","key":"10.1016\/j.diabres.2026.113156_b0335","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1136\/jclinpath-2011-200524","article-title":"Managing demand for laboratory tests: a laboratory toolkit","volume":"66","author":"Fryer","year":"2013","journal-title":"J Clin Pathol"},{"issue":"8","key":"10.1016\/j.diabres.2026.113156_b0340","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0237159","article-title":"Evaluation and cost estimation of laboratory test overuse in 43 commonly ordered parameters through a Computerized Clinical Decision support System (CCDSS) in a large university hospital","volume":"15","author":"Tamburrano","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.diabres.2026.113156_b0345","doi-asserted-by":"crossref","first-page":"145","DOI":"10.23736\/S1973-9087.24.08435-1","article-title":"Introduction to target trial emulation in rehabilitation: a systematic approach to emulate a randomized controlled trial using observational data","volume":"60","author":"C\u00f4t\u00e9","year":"2024","journal-title":"Eur J Phys Rehabil Med"},{"issue":"24","key":"10.1016\/j.diabres.2026.113156_b0350","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1001\/jama.2022.21383","article-title":"Target trial emulation: a framework for causal inference from observational data","volume":"328","author":"Hern\u00e1n","year":"2022","journal-title":"J Am Med Assoc"},{"issue":"2","key":"10.1016\/j.diabres.2026.113156_b0355","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4093\/dmj.2017.41.2.81","article-title":"A clinical practice guideline to guide a system approach to diabetes care in Hong Kong","volume":"41","author":"Lau","year":"2017","journal-title":"Diabetes Metab J"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726000756?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726000756?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T01:47:07Z","timestamp":1780105627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822726000756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":71,"alternative-id":["S0168822726000756"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113156","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimising lipid monitoring interval for primary prevention of cardiovascular disease in patients with type-2 diabetes: A target trial emulation study","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113156","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113156"}}